(Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-(methyl-13C)-5-oxo-1,5-dihydro-4H-pyrazol-4-ylidene-3,4,5-13C3)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag-13C4 is a fully characterized chemical compound used as a reference standard of API Eltrombopag. The standard offered is compliant with regulatory guidelines. Eltrombopag-13C4 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
